What management is there for Gonorrhea in the postquinolone era?

被引:13
作者
Tapsall, JW [1 ]
机构
[1] Prince Wales Hosp, Dept Pathol, WHO, Collaborat Ctr STD & HIV, Sydney, NSW, Australia
关键词
D O I
10.1097/01.olq.0000194599.97426.a3
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:8 / 10
页数:3
相关论文
共 31 条
[11]  
LEWIS DA, 2005, 16 BIENN M INT SOC S
[12]   Minimising antibiotic resistance [J].
Livermore, DM .
LANCET INFECTIOUS DISEASES, 2005, 5 (07) :450-459
[13]   The antibiotic susceptibility of Neisseria gonorrhoeae isolated in Ulaanbaatar, Mongolia [J].
Lkhamsuren, E ;
Shultz, TR ;
Limnios, EA ;
Tapsall, JW .
SEXUALLY TRANSMITTED INFECTIONS, 2001, 77 (03) :218-219
[14]  
*MAN SEX TRANSM DI, 1997, WHOGPATEM941, V1, P37
[15]  
MARTIN IMC, 2005, 16 BIENN M INT SOC S
[16]  
MOODLEY P, 2005, 16 BIENN M INT SOC S
[17]   Outbreak of cefozopran (Penicillin, oral cephems, and aztreonam)-resistant Neisseria gonorrhoeae in Japan [J].
Muratani, T ;
Akasaka, S ;
Kobayashi, T ;
Yamada, Y ;
Inatomi, H ;
Takahashi, K ;
Matsumoto, T .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (12) :3603-3606
[18]   MOLECULAR EPIDEMIOLOGY OF GONORRHEA [J].
SARAFIAN, SK ;
KNAPP, JS .
CLINICAL MICROBIOLOGY REVIEWS, 1989, 2 :S49-S55
[19]   Correlation of in vitro susceptibilities to newer quinolones of naturally occurring quinolone-resistant Neisseria gonorrhoeae strains with changes in GyrA and ParC [J].
Shultz, TR ;
Tapsall, JW ;
White, PA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (03) :734-738
[20]  
Simonsen GS, 2004, B WORLD HEALTH ORGAN, V82, P928